
Senior Consolidation Accountant-1
Merck
Summary
The Global Controller's organization ensures the financial integrity of the company's results. As part of the Consolidation Accounting team, you will collaborate cross-functionally to ensure activities operate in a well-controlled financial environment.
Job description
The Senior Consolidation Accountant will be responsible for compilation and reporting of the Company's consolidated financial results in accordance with US GAAP, coordinating, preparing, and analyzing financial data utilized in the Annual Report and SEC 10Q and 10K filings. This role reports directly to the Associate Director of Consolidation Accounting.
Primary Responsibilities
- Interact with global subsidiaries, FP&A teams and HQ teams to understand company performance and enable accurate consolidation of financial results
- Assist with preparation of US GAAP Consolidated Income Statement, Balance Sheet, Cash Flow Statement and various footnotes and disclosures filed in 10Q and 10K with the SEC
- Prepare consolidation journal entries, including processing post-closing adjustments on behalf of business divisions/legal entities
- Perform in-depth reviews of financial statement accounts by analyzing account balances, researching variations, obtaining entity commentary, and ensuring proper US GAAP accounting
- Prepare ad hoc analyses/reports and assist with special projects to drive continuous improvement and efficiencies in financial reporting
- Participate on cross-functional teams to ensure proper accounting for entity acquisitions and divestitures
- Provide accounting guidance/instructions to business divisions/legal entities for various transactions
- Ensure compliance with Finance policies and procedures, internal controls, and S404 requirements
Requirements
- Bachelor's degree in Accounting
- Minimum of 2 years of demonstrated experience in an accounting related role, internal audit, or Big 4 public accounting
- Understanding of the relationship between income statement, balance sheet, and cash flow statement
- Understanding of translation of foreign entities' financial statements to US Dollars and principles of Consolidation Accounting
- Demonstrated ability to analyze financial reports for accuracy and reasonableness and to prepare and maintain supporting schedules
- Strong time management skills with ability to work effectively under set time schedules
- Ability to work well independently and as a team player under tight deadlines
- Highly developed organizational, analytical and communication skills and ability to collaborate across areas
- Strong technical accounting skills, attention to detail, and high level of accuracy
- Proficient experience working with Microsoft Excel
- Working knowledge of Financial Consolidation and Close System (FCCS) and SAP applications
- CPA or MBA
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.